1.
Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population
2.
3.
Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults
Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings